HomeTTI • CVE
add
Thiogenesis Therapeutics Corp
Previous close
$0.64
Day range
$0.64 - $0.70
Year range
$0.51 - $0.88
Market cap
36.25M CAD
Avg Volume
11.43K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.83M | 150.74% |
Net income | -1.90M | -191.63% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.84M | -62.91% |
Total assets | 1.94M | -61.69% |
Total liabilities | 1.48M | 380.96% |
Total equity | 456.84K | — |
Shares outstanding | 46.31M | — |
Price to book | 64.00 | — |
Return on assets | -180.81% | — |
Return on capital | -353.31% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.90M | -191.63% |
Cash from operations | -1.17M | -112.68% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -1.17M | -111.54% |
Free cash flow | -419.32K | -17.42% |
About
Founded
2018
Headquarters
Website
